Showing results (71-80 of 76) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Journal for Immunotherapy of Cancer|June 10, 2022
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activityAlexander Muik, Homer C Adams 3rd, Friederike Gieseke, et al.Ebiomedicine|June 28, 2023
Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activityIda H Hiemstra, Kim C M Santegoets, Maarten L Janmaat, et al.Molecular Cancer Therapeutics|June 30, 2026
Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability TradeoffsLouise A Koopman, Farshid Alemdehy, Stefanie A H de Poot, et al.Cancer Discovery|February 17, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid TumorsAlexander Muik, Elena Garralda, Isil Altintas, et al.British Journal of Pharmacology|December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: Ion channelsStephen P H Alexander, Alistair A Mathie, John A Peters, et al.British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Ion channelsStephen P H Alexander, Jörg Striessnig, Alasdair J Gibb, et al.Pageof 8